
Pwodwi Entwodiksyon
| 2,3-DIAMINOTOLUENE Enfòmasyon de baz |
| Non pwodwi: | 2,3-DIAMINOTOLÈN |
| Sinonim: | 2,3-Diaminotoluene (3-Methyl-o-phenylenediamine);2.3-DiaMinotol;2,3-Diaminetoluene;2,3-Diaminotoluone;{{ 11}}Methylbenzene-1,2-dyamin98%;2-Benzenediamin,3-methyl-1;{3-Methyl-1,{ {20}}benzèndyamin;3-metil-1,2-phenylenediamine[qr] |
| CAS: | 2687-25-4 |
| MF: | C7H10N2 |
| mw: | 122.17 |
| EINCS: | 220-248-5 |
| Kategori pwodwi: | Seri benzèn; Idrokarbur Aromatik (ranplase) & Dérivés; Blòk Konstriksyon; Sentèz Chimik; Konpoze Azòt; Blòk Konstriksyon òganik; Amin; Aromatik; Pwodwi Chimik rechèch Mutagenezis; Polyamin |
| Mol File: | 2687-25-4.mol |
![]() |
|
| 2,3-DIAMINOTOLUENE Pwopriyete Chimik |
| Pwen k ap fonn | 59-65 degre (lit.) |
| Pwen bouyi | 225 degre |
| dansite | 1.0343 (estimasyon ki graj) |
| endèks refraktif | 1.5103 (estimasyon) |
| Fp | 225 degre |
| tanperati depo. | Kenbe nan kote ki fè nwa, atmosfè inaktif, tanperati chanm |
| solubilite | Diklorometan |
| pka | 4.28±0.10(Prevwa) |
| fòm | Poud oswa kristal |
| koulè | Brown a mawon fonse |
| retni | 907184 |
| InChiKey | AXNUJYHFQHQHQZBE-UHFFFAOYSA-N |
| Referans baz done CAS | 2687-25-4(Referans baz done CAS) |
| Sistèm Rejis Sibstans EPA | 1,2-Benzenediamin, 3-methyl- (2687-25-4) |
| Enfòmasyon sou Sekirite |
| Kòd danje | Xn, Xi |
| Deklarasyon Risk | 20/21/22-36/37/38 |
| Deklarasyon Sekirite | 26-36-36/37/39 |
| RIDADÈ | 2811 |
| WGK Almay | 3 |
| RTECS | XS9550000 |
| Nòt danje | Danjere/Irite |
| tSCA | Wi |
| HazardClass | 6.1(b) |
| Pake Group | III |
| Kòd HS | 29214990 |
| Done Sibstans Danjre yo | 2687-25-4(Done Sibstans Danjere) |
| Toksisite | sourit, LD50, intraperitoneal, 286mg/kg (286mg/kg), Genetica Polonica. Vol. 26, paj. 109, 1985. |
| Enfòmasyon MSDS |
| Founisè | Lang |
|---|---|
| Sigmaaldrich | angle |
| ATRAVÈ | angle |
| ALFA | angle |
| 2, 3-DIAMINOTOLUENE Itilizasyon ak sentèz |
| Pwopriyete chimik | poud mawon |
| Itilizasyon | Endiktè nan aktivite CYP1A, ak posib kanserojèn mutagenic. |
| Deskripsyon jeneral | Yo te etidye aktivite antitumoral Pd(II) ak Pt(II) nouvo konplèks ak 2,3-diaminotoluene. 2, 3-Diaminotoluene pwovoke aktivite CYP1A. |
| 2, 3-DIAMINOTOLUENE Preparasyon pwodwi ak matyè premyè |
| Preparasyon pwodwi yo | 4-methyl-1H-benzotriazole-->7-bromobenzo[c][1,2,5]thiadiazole-4-carbonitrile-->7-bromo-benzo[c][1,2,5]thiadiazole-4-carbaldehyde-->toluene-3,5-diamine-->2H-Benzimidazole-2-thione,1,3-dihydro-4-methyl-(9CI)-->4-(4-METHYL-1 H-BENZOIMIDAZOL-2-YL)-PHENYLAMINE-->1H-benzimidazol, 4-metil-2- (trifluorometil)-(9CI) |
Baj popilè: 2,3-diaminotoluene, Lachin 2,3-diaminotoluene manifaktirè, founisè, faktori
Ou ka renmen tou
Voye rechèch








